Related Experiment Video
Updated: May 27, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Insulin resistance and metabolic syndrome: is Helicobacter pylori criminal?
A Eshraghian1, H Eshraghian, G Ranjbar Omrani
1Department of Internal Medicine, Shiraz, Iran. eshraghiana@yahoo.com
Abstract:
Insulin resistance and metabolic syndrome are contributors to atherosclerosis and coronary heart disease. Insulin resistance is also responsible in pathogenesis of type II diabetes. Several studies previously evaluated the role of H. pylori infection in coronary heart disease and type II diabetes. Recently published data have described the association between H. pylori infection with insulin resistance and metabolic syndrome. However, this is still a controversial subject. Here in, we reviewed current status and present data toward this topic.
Related Concept Videos
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
